Published: Mon, February 26, 2018
Medical | By Johnnie Horton

Agios Pharmaceuticals (AGIO) Given Buy Rating at SunTrust Banks


Eos Management Lp sold 160,000 shares as the company's stock rose 10.32% with the market. Century Casinos had 5 analyst reports since August 11, 2015 according to SRatingsIntel. Over the past five trading sessions it is 0%; -0.49% for the month; 3.57% for the last quarter; 18.02% for the past six-months; and 63.71% for the last 12 months. About 3,473 shares traded. Century Casinos, Inc. (NASDAQ:CNTY) has risen 33.22% since February 25, 2017 and is uptrending. It has outperformed by 85.92% the S&P500. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Agios Pharmaceuticals by 41.5% in the 4th quarter. (AGIO) by 4.17% based on its latest 2017Q3 regulatory filing with the SEC.

Sell-side analyst recommendations point to a short term price target of $14.5 on the shares of RadNet, Inc. The biopharmaceutical company reported ($1.81) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.65) by ($0.16). The stock has a market capitalization of $4,750.00, a P/E ratio of -12.29 and a beta of 2.12.

Shares of Agios Pharmaceuticals (AGIO) traded up $1.02 during trading hours on Friday, hitting $82.83.

Agios Pharmaceuticals (NASDAQ:AGIO) last announced its quarterly earnings results on Wednesday, February 14th. It has underperformed by 8.18% the S&P500.

Among 3 analysts covering The Hackett Group (NASDAQ:HCKT), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 31% are positive.

Analysts await Agios Pharmaceuticals, Inc. (NASDAQ:HCKT) earned "Buy" rating by Roth Capital on Thursday, November 9. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Oppenheimer has a "Market Perform" rating on the stock. They expect $1.32 earnings per share, up 16.81% or $0.19 from last year's $1.13 per share. After $0.38 actual EPS reported by Addus HomeCare Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

In other Agios Pharmaceuticals news, Director Lewis Clayton Jr. It is negative, as 12 investors sold Century Casinos, Inc. shares while 17 reduced holdings.

The Navios Maritime Acquisition (NNA) Earns Daily News Impact Score of 0.19
During current year the company's forecasts over growth are -83.3% while for the next year analysts' growth estimation is 163.6%. Virtu KCG Holdings LLC acquired a new position in Navios Maritime Midstream Partners during the 2nd quarter valued at $266,000.

Investors sentiment decreased to 1.41 in Q3 2017. Its up 0.01, from 0.99 in 2017Q2. 11 funds opened positions while 30 raised stakes. Voya Inv Mgmt Limited Liability Corp owns 15,557 shares. Douglass Winthrop Advisors Lc has 0.02% invested in Accenture plc (NYSE:ACN) for 2,800 shares. 471 are held by Ameritas Prtnrs. National Bank & Trust Of America De holds 0% or 21,807 shares in its portfolio. The Massachusetts-based Fernwood Investment Management Llc has invested 1.16% in the stock. (NASDAQ:AGIO) or 4,000 shares. Pictet Asset Ltd owns 54,700 shares. Proshare Ltd invested in 0.02% or 28,244 shares. Invesco accumulated 0% or 8,229 shares. Loomis Sayles & Co LP holds 211,598 shares. 7,498 are held by Bluecrest Cap Management. Ahl Partners Limited Liability Partnership reported 6,971 shares. Ww accumulated 0.01% or 663,000 shares. (NASDAQ:AGIO) to report earnings on May, 3. During the same quarter previous year, the company posted ($1.34) earnings per share.

Wall Street analysts forecast that Agios Pharmaceuticals Inc (NASDAQ:AGIO) will report earnings per share (EPS) of ($1.60) for the current quarter, Zacks Investment Research reports.

Since September 1, 2017, it had 0 insider buys, and 22 insider sales for $24.95 million activity.

In other Agios Pharmaceuticals news, insider Scott Biller sold 2,146 shares of Agios Pharmaceuticals stock in a transaction on Friday, December 1st. Agios Pharmaceuticals has $132 highest and $47 lowest target.

Donald Chiboucis decreased its stake in Agios Pharmaceuticals Inc (AGIO) by 27.23% based on its latest 2017Q3 regulatory filing with the SEC. (NASDAQ:AGIO). Moreover, Bb Biotech Ag has 5.08% invested in Agios Pharmaceuticals, Inc. SunTrust Banks restated a "buy" rating and set a $101.00 price target (up from $80.00) on shares of Agios Pharmaceuticals in a report on Thursday, February 15th. Therefore 75% are positive. BidaskClub cut shares of Agios Pharmaceuticals from a "sell" rating to a "strong sell" rating in a research report on Saturday, December 16th. As per Wednesday, September 20, the company rating was initiated by Roth Capital. The legal version of this piece can be read at https://www.thelincolnianonline.com/2018/02/25/agios-pharmaceuticals-agio-upgraded-to-hold-by-valuengine-updated-updated.html. (NASDAQ:AGIO) on Monday, September 11. (NASDAQ:AGIO). 241,337 are owned by Int Limited Ca. On Friday, September 29 the stock rating was maintained by RBC Capital Markets with "Outperform". The rating was maintained by JP Morgan with "Overweight" on Thursday, February 15. The rating was maintained by Oppenheimer with "Buy" on Sunday, June 11. (NASDAQ:AGIO) on Wednesday, January 10. The firm has "Neutral" rating given on Monday, March 28 by Citigroup. Finally, Bank of Montreal Can increased its stake in Agios Pharmaceuticals by 74.8% in the 4th quarter. Hoerter Steven L. also sold $1.87 million worth of Agios Pharmaceuticals, Inc.

Investors sentiment decreased to 1.21 in 2017 Q3. Its down 0.83, from 2.04 in 2017Q2. It turned negative, as 22 investors sold AGIO shares while 44 reduced holdings. 97 funds opened positions while 315 raised stakes. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Bnp Paribas Asset Mngmt Hldgs reported 256,086 shares stake. Parametric Port Associate Ltd reported 0% stake. Park Avenue Securities Limited Liability reported 0.12% of its portfolio in Accenture plc (NYSE:ACN). (NASDAQ:AGIO). Oppenheimer Asset Mgmt Incorporated holds 0% of its portfolio in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Tuesday, January 23. Rhumbline Advisers holds 45,785 shares. Nationwide Fund Advsrs owns 0% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Ameriprise Fincl Incorporated holds 57,504 shares. Bancorporation Of Ny Mellon holds 251,306 shares or 0% of its portfolio. (NASDAQ:CNTY). California Pub Employees Retirement System has 62,300 shares. Brown Advisory reported 0.06% stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Like this: